Skip to main content
Journal of Enzyme Inhibition and Medicinal Chemistry logoLink to Journal of Enzyme Inhibition and Medicinal Chemistry
. 2018 Feb 2;33(1):433. doi: 10.1080/14756366.2018.1433261

Correction to: Fischer et al., Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance

PMCID: PMC7011846  PMID: 29390895

Fischer T, Najjar A, Totzke F, Schächtele C, Sippl W, Ritter C and Hilgeroth A. (2017). Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance. Journal of Enzyme Inhibition and Medicinal Chemistry. 33:1–8. https://doi.org/10.1080/14756366.2017.1370583.

When the article was first published online, the name of one co-author was incorrectly written as Karim Najjar. This has now been corrected in the online version as ‘Abdulkarim Najjar’.

The authors apologise for this error.


Articles from Journal of Enzyme Inhibition and Medicinal Chemistry are provided here courtesy of Taylor & Francis

RESOURCES